Overview

Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients

Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
This is a phase II study to observe efficacy of combining local radiotherapy with PD-1blockade in patients with advanced solid tumors. All patients will accept at least one site of radiotherapy together with PD-1 blockade. The study will evaluate changes of unirradiated and irradiated lesions.
Phase:
Phase 2
Details
Lead Sponsor:
Ruijin Hospital
Treatments:
Antibodies
Antibodies, Blocking